Correlation Between Cyclo Therapeutics and Mallinckrodt Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyclo Therapeutics and Mallinckrodt Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclo Therapeutics and Mallinckrodt Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclo Therapeutics and Mallinckrodt Plc, you can compare the effects of market volatilities on Cyclo Therapeutics and Mallinckrodt Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclo Therapeutics with a short position of Mallinckrodt Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclo Therapeutics and Mallinckrodt Plc.

Diversification Opportunities for Cyclo Therapeutics and Mallinckrodt Plc

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Cyclo and Mallinckrodt is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and Mallinckrodt Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mallinckrodt Plc and Cyclo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclo Therapeutics are associated (or correlated) with Mallinckrodt Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mallinckrodt Plc has no effect on the direction of Cyclo Therapeutics i.e., Cyclo Therapeutics and Mallinckrodt Plc go up and down completely randomly.

Pair Corralation between Cyclo Therapeutics and Mallinckrodt Plc

Given the investment horizon of 90 days Cyclo Therapeutics is expected to generate 0.46 times more return on investment than Mallinckrodt Plc. However, Cyclo Therapeutics is 2.17 times less risky than Mallinckrodt Plc. It trades about -0.01 of its potential returns per unit of risk. Mallinckrodt Plc is currently generating about -0.21 per unit of risk. If you would invest  147.00  in Cyclo Therapeutics on August 31, 2024 and sell it today you would lose (83.00) from holding Cyclo Therapeutics or give up 56.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy8.56%
ValuesDaily Returns

Cyclo Therapeutics  vs.  Mallinckrodt Plc

 Performance 
       Timeline  
Cyclo Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cyclo Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Cyclo Therapeutics is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Mallinckrodt Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mallinckrodt Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Mallinckrodt Plc is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Cyclo Therapeutics and Mallinckrodt Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyclo Therapeutics and Mallinckrodt Plc

The main advantage of trading using opposite Cyclo Therapeutics and Mallinckrodt Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclo Therapeutics position performs unexpectedly, Mallinckrodt Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mallinckrodt Plc will offset losses from the drop in Mallinckrodt Plc's long position.
The idea behind Cyclo Therapeutics and Mallinckrodt Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios